Bacillus Calmette-Guerin (BCG) for bladder cancerReferencesCitationsSylvester RJ, et al. (2004). Intravesical Bacillus
Calmette-Guerin reduces the risk of progression in patients with superficial
bladder cancer: A meta-analysis of the published results of randomized clinical
trials. Journal of Urology, 168(5):
1964–1970. Boyd LA (2003). Intravesical Bacillus Calmette-Guerin
for treating bladder cancer. Urologic Nursing, 23(3):
189–199.
| | Author: | Douglas Dana Shannon Erstad, MBA/MPH | Last Updated: July 9, 2007 | | Medical Review: | Anne C. Poinier, MD - Internal Medicine E. Gregory Thompson, MD - Internal Medicine Philip Belitsky, MD, FRCSC - Urology | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |